Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam besylate combined with alfentanil for sedation during gastrointestinal endoscopy
ChiCTR2100043964Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of Zhengzhou University
- Start
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of remimazolam, alfentanil and propofol in gastrointestinal conditions (4 arms), sponsored by The First Affiliated Hospital of Zhengzhou University. Primary endpoints: Integrated Pulmonary Index, Incidence of intraoperative respiratory depression and 1 more. Started Feb 2021; status: recruiting.
02
Drugs
remimazolamalfentanilpropofol
03
Conditions
gastrointestinal conditions
Beyond the preview
Go deeper on ChiCTR2100043964.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100043964.